Phenotypical features of a heterozygous form of familial hypercholesterolemia

被引:0
|
作者
Malyshev, P. P.
Rozhkova, T. A.
Solovyeva, E. Yu.
Meshkov, A. N.
Kaminnaya, V. I.
Kukharchuk, V. V.
机构
关键词
familial hypercholesterolemia; xanthomas; cholesterol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To conduct a quantitative and qualitative analysis of phenotypical manifestations in patients with a heterozygous form of familial hypercholesterolemia (FHC) and to reveal factors involved in their development. Material and methods. A total of 247 patients with a clinical diagnosis of heterozygous FHC participated in the trial. Clinical manifestations of the disease in men and women were analysed and compared. Blood lipids were compared to those in the controls. A correlation analysis was used to reveal correlations between symptoms of the disease and lipid levels in the blood. Results. Tendon xanthomas were most frequent (79916) clinical sign with location primarily in Achilles' tendon. Incidence of basic clinical manifestations increased with age and significantly correlated with LDLP cholesterol. Two clinical signs were seen in 113 of the patients, three - in 13% (sex differences were insignificant). Mean levels of total cholesterol and LDLP serum cholesterol in heterozygous patients were 1.9 and 2.5 times higher than in the controls. Total cholesterol was significantly higher in women. A mean level of HDLP cholesterol was significantly lower while triglycerides were higher than in the control group. The disease symptoms manifested in men 5 years earlier than in women, FHC was diagnosed in men 7 5 years earlier. Conclusion. Patients with heterozygous FHC are characterized by higher levels of LDLP cholesterol, lower level of HDLP cholesterol and higher triglycerides in the serum than in healthy controls. Sex-related differences by severity and prevalence of basic symptoms in heterozygous FHC patients were not found. The time of clinical symptoms appearance and diagnosis evidences for more rapid progression of the disease in men.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [1] Genetic screening for homozygous and heterozygous familial hypercholesterolemia
    Izar, Maria C.
    Machado, Valeria A.
    Fonseca, Francisco A.
    APPLICATION OF CLINICAL GENETICS, 2010, 3 : 147 - 157
  • [2] Emerging Treatments for Heterozygous and Homozygous Familial Hypercholesterolemia
    Baum, Seth J.
    Soifer, Daniel
    Duell, P. Barton
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2016, 17 (1-2) : 17 - 25
  • [3] The Detection of Heterozygous Familial Hypercholesterolemia in Ireland
    Maurice J. O’Kane
    Ian B. Menown
    Ian Graham
    Vincent Maher
    Gerald Tomkin
    Paul Nicholls
    Colin Graham
    Advances in Therapy, 2012, 29 : 456 - 463
  • [4] Identification of people with heterozygous familial hypercholesterolemia
    Haase, Annie
    Goldberg, Anne C.
    CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (04) : 282 - 289
  • [5] The Detection of Heterozygous Familial Hypercholesterolemia in Ireland
    O'Kane, Maurice J.
    Menown, Ian B.
    Graham, Ian
    Maher, Vincent
    Tomkin, Gerald
    Nicholls, Paul
    Graham, Colin
    ADVANCES IN THERAPY, 2012, 29 (05) : 456 - 463
  • [6] SERUM APOLIPOPROTEINS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    KAJINAMI, K
    MABUCHI, H
    KOIZUMI, J
    TAKEDA, R
    CLINICA CHIMICA ACTA, 1992, 211 (1-2) : 93 - 99
  • [7] Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Kallend, David
    Ray, Kausik K.
    Turner, Traci
    Koenig, Wolfgang
    Wright, R. Scott
    Wijngaard, Peter L. J.
    Curcio, Danielle
    Jaros, Mark J.
    Leiter, Lawrence A.
    Kastelein, John J. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1520 - 1530
  • [8] Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia
    Gaudet, Daniel
    Ruzza, Andrea
    Bridges, Ian
    Maruff, Paul
    Schembri, Adrian
    Hamer, Andrew
    Mach, Francois
    Bergeron, Jean
    Gaudet, Isabelle
    St Pierre, Julie
    Kastelein, John J. P.
    Hovingh, G. . Kees
    Wiegman, Albert
    Raal, Frederick J.
    Santos, Raul D.
    HAUSER-RCT Investigators
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (05) : 676 - 684
  • [9] High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry OCR
    Beliard, Sophie
    Boccara, Franck
    Cariou, Bertrand
    Carrie, Alain
    Collet, Xavier
    Farnier, Michel
    Ferrieres, Jean
    Krempf, Michael
    Peretti, Noel
    Rabes, Jean-Pierre
    Varret, Mathilde
    Vimont, Alexandre
    Charriere, Sybil
    Bruckert, Eric
    ATHEROSCLEROSIS, 2018, 277 : 334 - 340
  • [10] NEW COMBINED THERAPY OF NICERITROL AND PROBUCOL ON HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    YAMAMOTO, K
    FUKUSHIMA, N
    OZAKI, I
    SETOGUCHI, Y
    YANAGITA, T
    SAKAI, T
    ARTERY, 1991, 18 (03) : 133 - 149